Tail of Spence

Last updated
Tail of Spence
Illu lymph chain03.jpg
Lymph nodes - #3 and #4 are in the region of the tail of Spence.
Details
Identifiers
Latin processus axillaris,
processus lateralis mammae
TA98 A16.0.02.007
TA2 7100
FMA 58072
Anatomical terminology

The tail of Spence (Spence's tail, axillary process, axillary tail) has historically been described as an extension of the tissue of the upper outer quadrant of the breast traveling into the axilla. [1] The "axillary tail" has been reported to pass into the axilla through an opening in the deep fascia called foramen of Langer. The "tail of Spence" was named after the Scottish surgeon James Spence, who served as a President of the Royal College of Surgeons in Edinburgh in the latter half of the 19th Century. [2] [3] [4]

Contents

A recent publication has presented an updated description of the anatomy of the breast and upper outer chest, calling into question the concept of an axillary tail. The report does not challenge that lymphatic drainage consistently extends from the primary breast into the axilla through the foramen of Langer, but does demonstrate that a superolaterally oriented "tail" of breast fat (with or without ductal tissue) is rarely if ever present. Instead, upper lateral chest anatomy is consistently composed of the primary breast itself, a discrete axillary breast mound, and a lateral chest wall tail that never travels superiorly. [5] A review of historical literature shows that Spence himself never wrote that adipose or breast-tissue extends into the axilla. He only published that surgeons should not operate on breast cancer if they found "an undefined tail-like projection creeping up from the breast towards the axilla”, as though referring to the tumor tissue itself. [6] Spence's peers interpreted his remarks and published with differing descriptions, blurring anatomic understanding. [7] [8] Since 1871, a notion evolved of a tail-like extension of fatty tissue originating from the upper outer portion of the breast and traveling into the axilla. Over the next 150 years, the concept became engrained in medical parlance and literature, even though there has never been a detailed anatomic description or published anatomic data to support the anecdotal mention made by Spence and described in various ways by other authors.

At present, the breast is divided into quadrants for clinical reporting and oncological management purposes. It has been solidly established that tumor extension through lymphatics that travel in a contiguous chain from the primary breast into the axilla remains a poor oncologic prognosticator, especially when tumor originates in the upper outer quadrant of the breast. [9] However, for anatomic clarity, oncologists and surgeons may want to consider that the adjacent but separate axillary mound is not a tissue extension of the primary breast. Instead, there is a growing awareness that separate focal vestigial breast mounds are consistently present in adults, located in pairs running down the curved lines of the embryological mammary ridges. [10] It may be of great oncologic and surgical benefit if breast cancer formation and metastasis were reinterpreted in light of this new anatomic understanding. For example, it appears that the axillary mound is more likely to contain accessory ductal tissue than any of the other accessory fatty mounds along each mammary chain, perhaps more commonly serving as a nidus for breast cancer formation, though incidence of tumor formation in the other vestigial breast mounds has not been established.

Breast cancer

Breast cancer can develop in the tail of Spence. One form is referred to as carcinoma of the axillary tail of Spence (CATS). Various studies have calculated CATS as representing 0.1-1% of breast cancers. [11] [9] These cancers may actually represent de novo tumors forming in the anatomically separate axillary breast mounds that were previously thought to be tail-like extensions of the primary breast. [5]

See also

Related Research Articles

<span class="mw-page-title-main">Mastectomy</span> Surgical removal of one or both breasts

Mastectomy is the medical term for the surgical removal of one or both breasts, partially or completely. A mastectomy is usually carried out to treat breast cancer. In some cases, women believed to be at high risk of breast cancer have the operation as a preventive measure. Alternatively, some women can choose to have a wide local excision, also known as a lumpectomy, an operation in which a small volume of breast tissue containing the tumor and a surrounding margin of healthy tissue is removed to conserve the breast. Both mastectomy and lumpectomy are referred to as "local therapies" for breast cancer, targeting the area of the tumor, as opposed to systemic therapies, such as chemotherapy, hormonal therapy, or immunotherapy.

<span class="mw-page-title-main">Lymphatic system</span> Organ system in vertebrates complementary to the circulatory system

The lymphatic system, or lymphoid system, is an organ system in vertebrates that is part of the immune system, and complementary to the circulatory system. It consists of a large network of lymphatic vessels, lymph nodes, lymphoid organs, lymphoid tissues and lymph. Lymph is a clear fluid carried by the lymphatic vessels back to the heart for re-circulation. The Latin word for lymph, lympha, refers to the deity of fresh water, "Lympha".

<span class="mw-page-title-main">Metastasis</span> Spread of a disease inside a body

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.

<span class="mw-page-title-main">Carcinoma</span> Malignancy that develops from epithelial cells

Carcinoma is a malignancy that develops from epithelial cells. Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.

<span class="mw-page-title-main">Axilla</span> Area of the human body beneath the joint between arm and torso

The axilla is the area on the human body directly under the shoulder joint. It includes the axillary space, an anatomical space within the shoulder girdle between the arm and the thoracic cage, bounded superiorly by the imaginary plane between the superior borders of the first rib, clavicle and scapula, medially by the serratus anterior muscle and thoracolumbar fascia, anteriorly by the pectoral muscles and posteriorly by the subscapularis, teres major and latissimus dorsi muscle.

<span class="mw-page-title-main">Lymphadenectomy</span> Medical procedure

Lymphadenectomy, or lymph node dissection, is the surgical removal of one or more groups of lymph nodes. It is almost always performed as part of the surgical management of cancer. In a regional lymph node dissection, some of the lymph nodes in the tumor area are removed; in a radical lymph node dissection, most or all of the lymph nodes in the tumor area are removed.

<span class="mw-page-title-main">Lumpectomy</span> Limited surgical removal of breast tissue

Lumpectomy is a surgical removal of a discrete portion or "lump" of breast tissue, usually in the treatment of a malignant tumor or breast cancer. It is considered a viable breast conservation therapy, as the amount of tissue removed is limited compared to a full-breast mastectomy, and thus may have physical and emotional advantages over more disfiguring treatment. Sometimes a lumpectomy may be used to either confirm or rule out that cancer has actually been detected. A lumpectomy is usually recommended to patients whose cancer has been detected early and who do not have enlarged tumors. Although a lumpectomy is used to allow for most of the breast to remain intact, the procedure may result in adverse affects that can include sensitivity and result in scar tissue, pain, and possible disfiguration of the breast if the lump taken out is significant. According to National Comprehensive Cancer Network guidelines, lumpectomy may be performed for ductal carcinoma in situ (DCIS), invasive ductal carcinoma, or other conditions.

<span class="mw-page-title-main">Mammary ridge</span> Primordium specific for the development of the mammary gland

The mammary ridge or mammary crest is a primordium specific for the development of mammary glands.

<span class="mw-page-title-main">Radical mastectomy</span> Removal of cancerous breast

Radical mastectomy is a surgical procedure that treats breast cancer by removing the breast and its underlying chest muscle, and lymph nodes of the axilla (armpit). Breast cancer is the most common cancer among women. During the early twentieth century it was primarily treated by surgery, when the mastectomy was developed. However, with the advancement of technology and surgical skills in recent years, mastectomies have become less invasive. As of 2016, a combination of radiotherapy and breast conserving mastectomy are considered optimal treatment.

<span class="mw-page-title-main">Axillary lymph nodes</span> Lymph nodes in the human armpit

The axillary lymph nodes or armpit lymph nodes are lymph nodes in the human armpit. Between 20 and 49 in number, they drain lymph vessels from the lateral quadrants of the breast, the superficial lymph vessels from thin walls of the chest and the abdomen above the level of the navel, and the vessels from the upper limb. They are divided in several groups according to their location in the armpit. These lymph nodes are clinically significant in breast cancer, and metastases from the breast to the axillary lymph nodes are considered in the staging of the disease.

A fat pad is a mass of closely packed fat cells surrounded by fibrous tissue septa. They may be extensively supplied with capillaries and nerve endings.

<span class="mw-page-title-main">Human vestigiality</span> Human traits which lost their original function through evolution

In the context of human evolution, human vestigiality involves those traits occurring in humans that have lost all or most of their original function through evolution. Although structures called vestigial often appear functionless, a vestigial structure may retain lesser functions or develop minor new ones. In some cases, structures once identified as vestigial simply had an unrecognized function. Vestigial organs are sometimes called rudimentary organs. Many human characteristics are also vestigial in other primates and related animals.

A micrometastasis is a small collection of cancer cells that has been shed from the original tumor and spread to another part of the body through the lymphovascular system. Micrometastases are too few in size and quantity to be picked up in a screening or diagnostic test, and therefore cannot be seen with imaging tests such as a mammogram, MRI, ultrasound, PET, or CT scans. These migrant cancer cells may group together to form a second tumor, which is so small that it can only be seen under a microscope. Approximately 90 per cent of people who die from cancer die from metastatic disease, since these cells are so challenging to detect. It is important for these cancer cells to be treated immediately after discovery, in order to prevent the relapse and the likely death of the patient.

Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy and systemic treatment. Local therapy is most efficacious in early stage breast cancer, while systemic therapy is generally justified in advanced and metastatic disease, or in diseases with specific phenotypes.

Breast cancer classification divides breast cancer into categories according to different schemes criteria and serving a different purpose. The major categories are the histopathological type, the grade of the tumor, the stage of the tumor, and the expression of proteins and genes. As knowledge of cancer cell biology develops these classifications are updated.

<span class="mw-page-title-main">Male breast cancer</span> Medical condition

Male breast cancer (MBC) is a cancer in males that originates in their breasts. Males account for less than 1% of new breast cancers with about 20,000 new cases being diagnosed worldwide every year. Its incidence rates in males vs. females are, respectively, 0.4 and 66.7 per 100,000 person-years. The worldwide incidences of male as well as female breast cancers have been increasing over the last few decades. Currently, one of every 800 men are estimated to develop this cancer during their lifetimes.

<span class="mw-page-title-main">William Mitchell Banks</span>

Sir William Mitchell Banks was a Scottish surgeon. He was an early advocate of what is now called the modified radical mastectomy.

Mammary secretory carcinoma (MSC), also termed secretory carcinoma of the breast, is a rare form of the breast cancers. MSC usually affects women but in a significant percentage of cases also occurs in men and children. Indeed, McDvitt and Stewart first described MSC in 1966 and termed it juvenile breast carcinoma because an increased number of cases were at that time diagnosed in juvenile females. MSC is the most common form of breast cancer in children, representing 80% of childhood breast cancers, although it accounts for less than 0.15% of all breast cancers.

Secretory carcinoma was once used exclusively as a term for rare, slowly growing breast tumors without reference to their location in the breast. It is now termed mammary secretory carcinoma because secretory carcinoma has sometimes been used to name tumors which develop in non-breast tissues but have the microscopic appearance of, and a critical gene abnormality found in, mammary secretory carcinoma. This genetic abnormality is a balanced genetic translocation that forms a ETV6-NTRK3 fusion gene which appears involved in promoting the development and/or progression of all these tumors. The formerly termed secretory carcinomas include:

Papillary carcinomas of the breast (PCB), also termed malignant papillary carcinomas of the breast, are rare forms of the breast cancers. The World Health Organization (2019) classified papillary neoplasms of the breast into 5 types: intraductal papilloma, papillary ductal carcinoma in situ (PDCIS), encapsulated papillary carcinoma (EPC), solid-papillary carcinoma (SPC), and invasive papillary carcinoma (IPC). The latter four carcinomas are considered here; intraductal papilloma is a benign neoplasm. The World Health Organization regarded solid papillary carcinoma as having two subtypes: in situ and invasive SPC.

References

  1. ↑ Memon S, Emanuel JC (2008). "The axillary tail--an important caveat in prophylactic mastectomy". The Breast Journal. 14 (3): 313–314. doi: 10.1111/j.1524-4741.2008.00585.x . PMID   18373642. S2CID   21905267.
  2. ↑ Sebastian A (1999). A dictionary of the history of medicine. Carnforth, Lancs: Parthenon. p. 677. ISBN   1-85070-021-4.
  3. ↑ Risse, Guenter B. (1999). Mending bodies, saving souls : a history of hospitals. New York: Oxford University Press. p. 377. ISBN   978-0-19-974869-3. OCLC   228120261.{{cite book}}: CS1 maint: date and year (link)
  4. ↑ Biographical Index of Former Fellows of the Royal Society of Edinburgh 1783–2002. Edinburgh: Royal Society of Edinburgh. July 2006. ISBN   0-902-198-84-X.
  5. 1 2 Teplica D, Cooney E, Jeffers E, Sayers M (February 2022). "There is No "Axillary Tail": Rethinking the Assumption of James Spence". Plastic and Reconstructive Surgery. Global Open. 10 (2): e4086. doi:10.1097/GOX.0000000000004086. PMC   8830835 . PMID   35169519.
  6. ↑ Spence J (1871). Lectures on Surgery. Edinburgh, Scotland: Adam and Charles Black. p. 131.
  7. ↑ Bell J (February 1871). "Notes on Excision of the Mamma". Edinburgh Medical Journal. 16 (8): 687–691. PMC   5000365 .
  8. ↑ Stiles HJ (July 1892). "Contributions to the Surgical Anatomy of the Breast and Axillary Lymphatic Glands, Illustrated by Lime-Light and Microscopical Demonstrations". Transactions. Medico-Chirurgical Society of Edinburgh. 11: 37–70. PMC   5538522 . PMID   29584365.
  9. 1 2 Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM (2018). "Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study". Cancer Management and Research. 10: 1133–1141. doi: 10.2147/CMAR.S165291 . PMC   5958946 . PMID   29795985.
  10. ↑ Teplica D, Kovich G, Srock J, Whitaker R, Jeffers E, Wagstaff DA (October 2021). "Newly Identified Gross Human Anatomy: Eight Paired Vestigial Breast Mounds Run along the Embryological Mammary Ridges in Lean Adults". Plastic and Reconstructive Surgery. Global Open. 9 (10): e3863. doi:10.1097/GOX.0000000000003863. PMC   8517303 . PMID   34667697.
  11. ↑ Ampil F, Caldito G, Henderson B, Li B, Kim RH, Burton G, Chu Q (September 2012). "Carcinoma of the axillary tail of Spence: a case series". Anticancer Research. 32 (9): 4057–4059. PMID   22993360 . Retrieved 3 December 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.